Company: STAA
Filing Date: 2025-10-30
Form Type: DEFA14A
Source: 0001193125-25-258558
Chunk: 23

Company: STAAR SURGICAL CO
Filing Date: 2025-10-30
Form: DEFA14A
Chunk 23
---
 quarter 2025.

On October 21, 2025, the Board met to discuss matters related to the Special Meeting. Members of STAAR’s management and representatives of Citi, Wachtell Lipton and Innisfree attended the meeting. The Board considered, among other things, recent public statements made by the Broadwood Group and Yunqi Capital Limited regarding the proposed Merger, and updates from Mr. Farrell regarding his discussions with Mr. Endicott about potential next steps in connection with the Special Meeting and potential amendments to the Merger Agreement, as well as the possibility that Alcon may request that STAAR adopt a stockholder rights plan. The Board directed STAAR’s management to engage in further discussions with Alcon.

Also on October 21, 2025, the Broadwood Group notified the Board of its intent to call a special meeting of stockholders for the purpose of removing several of STAAR’s directors, and cautioned the Board not to take any procedural or substantive actions with respect to the proposed Merger in advance of the stockholder vote at the Special Meeting on October 23, 2025.

On October 22, 2025, the Board held a meeting to consider whether to adjourn the Special Meeting. Members of STAAR’s management and representatives of Citi, Wachtell Lipton and Innisfree attended the meeting. The Board considered, among other things, updates from Mr. Farrell, Citi and Wachtell Lipton regarding their ongoing discussions with Mr. Endicott, Morgan Stanley and Gibson Dunn, respectively, and guidance from Innisfree regarding the likely outcome of the Special Meeting if held as scheduled on October 23, 2025. In considering whether to adjourn the Special Meeting, the Board considered, among other things, (i) the varying views expressed by STAAR stockholders as to whether to proceed with the Special Meeting, including the Broadwood Group’s and Yunqi Capital Limited’s public opposition to the Merger, (ii) the need to solicit additional proxies in favor of the Merger Proposal and Compensation Proposal based on preliminary voting results, and the possibility that such preliminary voting results may be impacted by some stockholders’ expectation of an adjournment, (iii) the possibility that Alcon would agree to an increase in the Merger Consideration or other changes to the terms of the Merger Agreement, and (iv) the potential adverse impact on STAAR’s valuation in the event of a failed stockholder vote and termination of the